Stone RM - Search Results

1

Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412.

Stone RM, DeAngelo DJ, Klimek V, Galinsky I, Estey E, Nimer SD, Grandin W, Lebwohl D, Wang Y, Cohen P, Fox EA, Neuberg D, Clark J, Gilliland DG, Griffin JD. Stone RM, et al. Blood. 2005 Jan 1;105(1):54-60. doi: 10.1182/blood-2004-03-0891. Epub 2004 Sep 2. Blood. 2005. PMID: 15345597 Free article. Clinical Trial.

2

Hexamethylene bisacetamide in myelodysplastic syndrome and acute myelogenous leukemia: a phase II clinical trial with a differentiation-inducing agent.

Andreeff M, Stone R, Michaeli J, Young CW, Tong WP, Sogoloff H, Ervin T, Kufe D, Rifkind RA, Marks PA. Andreeff M, et al. Blood. 1992 Nov 15;80(10):2604-9. Blood. 1992. PMID: 1421378 Free article. Clinical Trial.

3

Risk factors for high-dose cytarabine neurotoxicity: an analysis of a cancer and leukemia group B trial in patients with acute myeloid leukemia.

Rubin EH, Andersen JW, Berg DT, Schiffer CA, Mayer RJ, Stone RM. Rubin EH, et al. Among authors: stone rm. J Clin Oncol. 1992 Jun;10(6):948-53. doi: 10.1200/JCO.1992.10.6.948. J Clin Oncol. 1992. PMID: 1588374 Clinical Trial.

4

Hematopoietic growth factors and leukemia.

Stone RM. Stone RM. Curr Opin Oncol. 1992 Feb;4(1):33-44. doi: 10.1097/00001622-199202000-00006. Curr Opin Oncol. 1992. PMID: 1591293

5

Inhibition of protein kinase C is associated with a decrease in c-myc expression in human myeloid leukemia cells.

Bernstein SH, Kharbanda SM, Sherman ML, Stone RM, Kufe DW. Bernstein SH, et al. Among authors: stone rm. FEBS Lett. 1991 Dec 2;294(1-2):73-6. doi: 10.1016/0014-5793(91)81346-a. FEBS Lett. 1991. PMID: 1743296 Free article.

6

Inhibition of phorbol ester-induced monocytic differentiation and c-fms gene expression by dexamethasone: potential involvement of arachidonic acid metabolites.

Stone RM, Imamura K, Datta R, Sherman ML, Kufe DW. Stone RM, et al. Blood. 1990 Sep 15;76(6):1225-32. Blood. 1990. PMID: 2144778 Free article.

7

The unique aspects of acute promyelocytic leukemia.

Stone RM, Mayer RJ. Stone RM, et al. J Clin Oncol. 1990 Nov;8(11):1913-21. doi: 10.1200/JCO.1990.8.11.1913. J Clin Oncol. 1990. PMID: 2230879 Review.

8

Bryostatin 1 activates protein kinase C and induces monocytic differentiation of HL-60 cells.

Stone RM, Sariban E, Pettit GR, Kufe DW. Stone RM, et al. Blood. 1988 Jul;72(1):208-13. Blood. 1988. PMID: 2455568 Free article.

9

Phospholipase C activates protein kinase C and induces monocytic differentiation of HL-60 cells.

Stone RM, Weber BL, Spriggs DR, Kufe DW. Stone RM, et al. Blood. 1988 Aug;72(2):739-44. Blood. 1988. PMID: 3165300 Free article.

10

Complete remission in acute promyelocytic leukemia despite persistence of abnormal bone marrow promyelocytes during induction therapy: experience in 34 patients.

Stone RM, Maguire M, Goldberg MA, Antin JH, Rosenthal DS, Mayer RJ. Stone RM, et al. Blood. 1988 Mar;71(3):690-6. Blood. 1988. PMID: 3422828 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

552 results

Search Page

Filters